Clinical Trials Logo
  1. Home
  2. Restless Legs Syndrome (RLS)
  3. NCT01382901

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome (RLS) Clinical Trial

Official title:
A Phase 2a Study Evaluating the Efficacy and Safety of a Novel Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Clinical Trial Summary

The purpose of this study was to evaluate the safety of 2 dosage regimens of Intravenous (IV) iron Ferric Carboxymaltose (FCM) in comparison to placebo in patients with Restless Legs Syndrome (RLS)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01382901
Study type Interventional
Source Luitpold Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date March 2006
Completion date July 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT00748098 - Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance Phase 3
Completed NCT00373542 - 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome Phase 4
Completed NCT01981941 - Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment Phase 4
Completed NCT01823770 - Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome Phase 4
Completed NCT00256854 - Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) Phase 3
Completed NCT03053427 - A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients Phase 4
Completed NCT01411124 - Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects Phase 1
Terminated NCT02826681 - Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia Phase 2
Completed NCT02397057 - Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS Phase 3
Completed NCT01494766 - Efficacy of Tyrosine in Restless Legs Syndrome N/A
Completed NCT00314860 - RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole Phase 3
Completed NCT00363857 - A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome Phase 3